Publicaciones en colaboración con investigadores/as de Instituto de Investigación Biomédica de Lleida (15)

2024

  1. Surrogate endpoints in phase III randomized trials of advanced gastroesophageal cancer: A systematic review and meta-analysis

    Critical Reviews in Oncology/Hematology, Vol. 201

2023

  1. Applications of CRISPR Technology to Breast Cancer and Triple Negative Breast Cancer Research

    Cancers, Vol. 15, Núm. 17

  2. MicroRNAs Present in Malignant Pleural Fluid Increase the Migration of Normal Mesothelial Cells In Vitro and May Help Discriminate between Benign and Malignant Effusions

    International journal of molecular sciences, Vol. 24, Núm. 18

  3. PLA2G12A as a Novel Biomarker for Colorectal Cancer with Prognostic Relevance

    International journal of molecular sciences, Vol. 24, Núm. 13

2022

  1. Are Transcription Factors Plausible Oncotargets for Triple Negative Breast Cancers?

    Cancers, Vol. 14, Núm. 5

  2. Cell-Free DNA Concentration and Pattern Fragmentation in Pleural Fluid and Plasma to Detect Malignant Effusions

    Annals of the American Thoracic Society

2021

  1. Diving into the pleural fluid: Liquid biopsy for metastatic malignant pleural effusions

    Cancers, Vol. 13, Núm. 11

  2. Microenvironmental reactive oxygen species in colorectal cancer: Involved processes and therapeutic opportunities

    Cancers, Vol. 13, Núm. 20

2020

  1. Prognostic factors involved in the epithelial– mesenchymal transition process in colorectal cancer have a preponderant role in oxidative stress: A systematic review and meta-analysis

    Cancers, Vol. 12, Núm. 11, pp. 1-28

2019

  1. Epithelial cell adhesion molecule (EpCAM) from pleural fluid cell lysates is a highly accurate diagnostic biomarker of adenocarcinomatous effusions

    Respirology, Vol. 24, Núm. 8, pp. 799-804

2018

  1. Circulating tumor cells (CTCs) and cytokeratin 19 (CK19) mRNA as prognostic factors in heavily pretreated patients with metastatic breast cancer

    Cancer Treatment and Research Communications, Vol. 16, pp. 13-17

2017

  1. Novel biomarkers in primary breast core biopsies to predict poor response to neoadjuvant chemotherapy and appearance of metastases

    Histology and Histopathology, Vol. 32, Núm. 9, pp. 909-915

  2. Prognosis of Cancer with Synchronous or Metachronous Malignant Pleural Effusion

    Lung, Vol. 195, Núm. 6, pp. 775-779

2014

  1. Prognostic value of c-FLIPL/s, HIF-1α, and NF-κβ in stage II and III rectal cancer

    Virchows Archiv, Vol. 464, Núm. 6, pp. 645-654

2008

  1. Rentabilidad del estudio citológico del líquido pleural en el derrame maligno

    Anales de Medicina Interna, Vol. 25, Núm. 4, pp. 173-177